SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001367644-15-000016
Filing Date
2015-03-06
Accepted
2015-03-06 14:42:04
Documents
8
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 2120829
2 exhibit12.htm EX-12.1 49213
3 exhibit21.htm EX-21 13409
4 exhibit23.htm EX-23.1 6349
5 exhibit31-1.htm EX-31.1 12672
6 exhibit31-2.htm EX-31.2 12619
7 exhibit32-1.htm EX-32.1 4578
8 exhibit32-2.htm EX-32.2 4543
  Complete submission text file 0001367644-15-000016.txt   2225217
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33137 | Film No.: 15681070
SIC: 2834 Pharmaceutical Preparations